The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The price of Progyny Inc (NASDAQ: PGNY) closed at $23.61 in the last session, down -0.71% from day before closing price of $23.78. In other words, the price has decreased by -$0.71 from its previous closing price. On the day, 0.94 million shares were traded. PGNY stock price reached its highest trading level at $23.9 during the session, while it also had its lowest trading level at $23.11.
Ratios:
We take a closer look at PGNY’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.90 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.34. For the most recent quarter (mrq), Quick Ratio is recorded 2.39 and its Current Ratio is at 2.39. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.
On December 02, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight but kept the price unchanged to $17.
Truist Downgraded its Buy to Hold on November 13, 2024, whereas the target price for the stock was revised from $26 to $19.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 11 ’25 when Scott Cheryl sold 2,675 shares for $22.07 per share. The transaction valued at 59,037 led to the insider holds 14,112 shares of the business.
Scott Cheryl bought 2,675 shares of PGNY for $59,039 on Jun 11 ’25. On Jun 03 ’25, another insider, Cohen Fred E, who serves as the Former Director of the company, bought 62,244 shares for $21.68 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGNY now has a Market Capitalization of 2023801984 and an Enterprise Value of 1658569600. As of this moment, Progyny’s Price-to-Earnings (P/E) ratio for their current fiscal year is 41.67, and their Forward P/E ratio for the next fiscal year is 28.47. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.67 while its Price-to-Book (P/B) ratio in mrq is 4.33. Its current Enterprise Value per Revenue stands at 1.367 whereas that against EBITDA is 21.633.
Stock Price History:
The Beta on a monthly basis for PGNY is 1.32, which has changed by -0.18445593 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, PGNY has reached a high of $30.42, while it has fallen to a 52-week low of $13.39. The 50-Day Moving Average of the stock is 7.80%, while the 200-Day Moving Average is calculated to be 20.43%.
Shares Statistics:
According to the various share statistics, PGNY traded on average about 1.11M shares per day over the past 3-months and 1452120 shares per day over the past 10 days. A total of 85.67M shares are outstanding, with a floating share count of 78.47M. Insiders hold about 8.46% of the company’s shares, while institutions hold 88.17% stake in the company. Shares short for PGNY as of 1749772800 were 6625645 with a Short Ratio of 5.95, compared to 1747267200 on 6758238. Therefore, it implies a Short% of Shares Outstanding of 6625645 and a Short% of Float of 10.71.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
